Rockwell Medical, Inc. (RMTI) — Financial statements
Income statement, balance sheet, and cash flow for Rockwell Medical, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | |
|---|---|---|
| Revenue & Gross Profit | ||
| Revenue | 69 | |
| Cost of Revenue | 58 | |
| Gross Profit | 12 | |
| Operating Expenses | ||
| R&D Expenses | 0.00 | |
| General & Administrative Expenses | 14,032 | |
| Selling & Marketing Expenses | 2,354 | |
| SG&A Expenses | 16,386 | |
| Other Expenses | -16,370 | |
| Operating Expenses | 16 | |
| Total Costs & Expenses | 74 | |
| Operating Results | ||
| Operating Income | -5 | |
| Depreciation & Amortization | 2 | |
| EBITDA | -2 | |
| EBIT | -4 | |
| Interest & Other Income | ||
| Net Interest Income | -0.89 | |
| Interest Income | 0.23 | |
| Interest Expense | 1 | |
| Non-Operating Income | -0.50 | |
| Other Income / Expenses | -0.62 | |
| Income Before Tax | -5 | |
| Income Tax Expense | 0.00 | |
| Net Income & EPS | ||
| Net Income from Continuing Operations | -5 | |
| Net Income from Discontinued Operations | 0.00 | |
| Net Income | -5 | |
| Bottom-Line Net Income | -5 | |
| EPS (Basic) | -1.50 | |
| EPS (Diluted) | -1.50 | |
| Weighted Average Shares | 4 | |
| Weighted Average Diluted Shares | 4 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.